Ronnie Shapira-Frommer

2 Sheba Road, 5266202
Ramat Gan, TA 52662, Israel

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 92 publications

Anti-CD19 CAR T-cell therapy as salvage treatment for refractory cutaneous polyarteritis nodosa.

Anti-CD19 CAR T-cell therapy as salvage treatment for refractory cutaneous polyarteritis nodosa.

Journal: Annals of the rheumatic diseases

Published: May 23, 2026

Oral anticoagulants reduce venous thromboembolism rates in patients on 1st-line treatment for ovarian Cancer- A quality improvement project.

Oral anticoagulants reduce venous thromboembolism rates in patients on 1st-line treatment for ovarian Cancer- A quality improvement project.

Journal: Gynecologic oncology

Published: April 02, 2026

Lenvatinib plus pembrolizumab in previously treated advanced endometrial cancer: 5-year outcomes from the randomized, phase 3 Study 309/KEYNOTE-775.

Lenvatinib plus pembrolizumab in previously treated advanced endometrial cancer: 5-year outcomes from the randomized, phase 3 Study 309/KEYNOTE-775.

Journal: Journal for immunotherapy of cancer

Published: January 20, 2026

Lenvatinib plus Pembrolizumab for Patients with Previously Treated Advanced Gastric, Biliary Tract, or Pancreatic Cancer: Results from the Phase II LEAP-005 Study.

Lenvatinib plus Pembrolizumab for Patients with Previously Treated Advanced Gastric, Biliary Tract, or Pancreatic Cancer: Results from the Phase II LEAP-005 Study.

Journal: Cancer research communications

Published: January 14, 2026

Vulvar and Vaginal Melanoma: Real-world Clinical Outcomes and Prognostic Differences From a Single-center Experience.

Vulvar and Vaginal Melanoma: Real-world Clinical Outcomes and Prognostic Differences From a Single-center Experience.

Journal: Journal of lower genital tract disease

Published: December 15, 2025

Anti-CD19 CAR-T cell therapy as rescue treatment in systemic sclerosis relapsing after autologous haematopoietic stem cell transplantation: a case series.

Anti-CD19 CAR-T cell therapy as rescue treatment in systemic sclerosis relapsing after autologous haematopoietic stem cell transplantation: a case series.

Journal: Rheumatology (Oxford, England)

Published: November 24, 2025

CAR-T as a salvage treatment in polyrefractory RA.

CAR-T as a salvage treatment in polyrefractory RA.

Journal: Rheumatology (Oxford, England)

Published: November 04, 2025

Engineered mRNA backbones for gene expression in human T cells.

Engineered mRNA backbones for gene expression in human T cells.

Journal: Molecular therapy. Nucleic acids

Published: August 15, 2025

Decoy antibodies block extracellular HSP70, prevent self-signaling, and inhibit melanoma cell survival.

Decoy antibodies block extracellular HSP70, prevent self-signaling, and inhibit melanoma cell survival.

Journal: Cell reports

Published: July 29, 2025

Ultrasensitive detection and tracking of circulating tumor DNA to predict relapse and survival in patients with locally advanced cervical cancer: phase III CALLA trial analyses.

Ultrasensitive detection and tracking of circulating tumor DNA to predict relapse and survival in patients with locally advanced cervical cancer: phase III CALLA trial analyses.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology

Published: April 23, 2025

Lenvatinib Plus Pembrolizumab for Patients With Previously Treated Advanced Colorectal Cancer: Results From the Phase II LEAP-005 Study.

Lenvatinib Plus Pembrolizumab for Patients With Previously Treated Advanced Colorectal Cancer: Results From the Phase II LEAP-005 Study.

Journal: Clinical colorectal cancer

Published: March 31, 2025

HLA export by melanoma cells decoys cytotoxic T cells to promote immune evasion.

HLA export by melanoma cells decoys cytotoxic T cells to promote immune evasion.

Journal: Cell

Published: January 08, 2025

Showing 1-12 of 92

Last Updated: 09/26/2026